{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:08:08Z","timestamp":1744258088286,"version":"3.40.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00198-016-3528-4","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T14:11:46Z","timestamp":1455804706000},"page":"2379-2382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Severe non-infective systemic inflammatory response syndrome, shock, and end-organ dysfunction after zoledronic acid administration in a child"],"prefix":"10.1007","volume":"27","author":[{"given":"S.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Al-Nofal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Kahoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Tebben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"key":"3528_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2217\/ijr.09.58","volume":"4","author":"LM Ward","year":"2009","unstructured":"Ward LM, Petryk A, Gordon CM (2009) Use of bisphosphonates in the treatment of pediatric osteoporosis. Int J Clin Rheumtol 4:657\u2013672","journal-title":"Int J Clin Rheumtol"},{"key":"3528_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/JPEM.2009.22.1.55","volume":"22","author":"JJ Brown","year":"2009","unstructured":"Brown JJ, Zacharin MR (2009) Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis. J Pediatr Endocr Metab 22:55\u201363","journal-title":"J Pediatr Endocr Metab"},{"key":"3528_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1515\/jpem-2012-0016","volume":"25","author":"ER Barros","year":"2012","unstructured":"Barros ER, Saraiva GL, de Oliveira TP, Lazaretti-Castro M (2012) Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta. J Pediatr Endocr Metab 25:485\u2013491","journal-title":"J Pediatr Endocr Metab"},{"key":"3528_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/pbc.22681","volume":"56","author":"KJ August","year":"2011","unstructured":"August KJ, Dalton A, Katzenstein HM, George B, Olson TA, Wasilewski-Masker K, Rapkin LB (2011) The use of zoledronic acid in pediatric cancer patients. Pediatr Blood Cancer 56:610\u2013614","journal-title":"Pediatr Blood Cancer"},{"key":"3528_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3346\/jkms.2010.25.9.1277","volume":"25","author":"MJ Lim","year":"2010","unstructured":"Lim MJ, Kwon SR, Park SG, Park W (2010) Acute effects of intravenous administration of pamidronate in patients with osteoporosis. J Korean Med Sci 25:1277\u20131283","journal-title":"J Korean Med Sci"},{"key":"3528_CR6","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250\u20131256","journal-title":"Crit Care Med"},{"key":"3528_CR7","doi-asserted-by":"crossref","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. (1992) Critical care medicine 20:864\u2013874","DOI":"10.1097\/00003246-199206000-00025"},{"key":"3528_CR8","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1097\/00003246-199711000-00014","volume":"25","author":"DJ Muckart","year":"1997","unstructured":"Muckart DJ, Bhagwanjee S (1997) American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 25:1789\u20131795","journal-title":"Crit Care Med"},{"key":"3528_CR9","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1007\/s00134-008-1160-2","volume":"34","author":"JM Dulhunty","year":"2008","unstructured":"Dulhunty JM, Lipman J, Finfer S, Grp ACT (2008) Does severe non-infectious SIRS differ from severe sepsis? Intensive Care Med 34:1654\u20131661","journal-title":"Intensive Care Med"},{"key":"3528_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1067\/mpd.2002.128207","volume":"141","author":"RC Henderson","year":"2002","unstructured":"Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ (2002) Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr-Us 141:644\u2013651","journal-title":"J Pediatr-Us"},{"key":"3528_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00247-004-1393-3","volume":"35","author":"LE Grissom","year":"2005","unstructured":"Grissom LE, Kecskemethy HH, Bachrach SJ, McKay C, Harcke HT (2005) Bone densitometry in pediatric patients treated with pamidronate. Pediatr Radiol 35:511\u2013517","journal-title":"Pediatr Radiol"},{"key":"3528_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jocd.2005.11.003","volume":"9","author":"SJ Bachrach","year":"2006","unstructured":"Bachrach SJ, Kecskemethy HH, Harcke HT, Lark RK, Miller F, Henderson RC (2006) Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy. J Clin Densitom 9:167\u2013174","journal-title":"J Clin Densitom"},{"key":"3528_CR13","first-page":"91","volume":"71","author":"N Allington","year":"2005","unstructured":"Allington N, Vivegnis D, Gerard P (2005) Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. Acta Orthop Belg 71:91\u201397","journal-title":"Acta Orthop Belg"},{"key":"3528_CR14","doi-asserted-by":"crossref","unstructured":"Sees JP, Sitoula P, Dabney K, Holmes L, Jr., Rogers KJ, Kecskemethy HH, Bachrach S, Miller F (2015) Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy. J Pediatr Orthop","DOI":"10.1097\/BPO.0000000000000421"},{"key":"3528_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947\u2013952","journal-title":"N Engl J Med"},{"key":"3528_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1210\/jc.2002-021371","volume":"88","author":"F Rauch","year":"2003","unstructured":"Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH (2003) Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986\u2013992","journal-title":"J Clin Endocrinol Metab"},{"key":"3528_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bone.2004.03.008","volume":"35","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Mier RJ, Glorieux FH (2004) Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone 35:231\u2013234","journal-title":"Bone"},{"key":"3528_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jpeds.2004.06.066","volume":"145","author":"W Hogler","year":"2004","unstructured":"Hogler W, Yap F, Little D, Ambler G, McQuade M, Cowell CT (2004) Short-term safety assessment in the use of intravenous zoledronic acid in children. J Pediatr-Us 145:701\u2013704","journal-title":"J Pediatr-Us"},{"key":"3528_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bone.2007.05.002","volume":"41","author":"CF Munns","year":"2007","unstructured":"Munns CF, Rajab MH, Hong J, Briody J, Hogler W, McQuade M, Little DG, Cowell CT (2007) Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone 41:366\u2013370","journal-title":"Bone"},{"key":"3528_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jbmr.1797","volume":"28","author":"JL Welton","year":"2013","unstructured":"Welton JL, Morgan MP, Mart\u00ed S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M (2013) Monocytes and \u03b3\u03b4 T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res 28:464\u2013471","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-016-3528-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3528-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3528-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3528-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:40:07Z","timestamp":1744173607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-016-3528-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3528"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3528-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2016,2,18]]},"assertion":[{"value":"27 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors received honoraria, grants, or other forms of payment to produce the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}